Tanabe Pharma America, Inc.

This study tested an experimental drug called MT-3921 in 72 people with a recent severe spinal cord injury in the neck. Participants received either the drug or a placebo by IV over 6 months. The main goal was to see if the drug improves arm and hand muscle function better than p…

This study tested an experimental drug called MT-7117 in 102 adults with erythropoietic protoporphyria (EPP), a rare condition that causes severe pain from sunlight exposure. The goal was to see if the drug could increase the time people could spend in the sun without symptoms. P…

This study tested an experimental drug called MT-7117 in 184 people aged 12 to 75 with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), conditions that cause severe pain from sunlight exposure. The goal was to see if the drug could increase the time it takes …

This study looked at the long-term safety of an oral form of edaravone in 124 people with ALS over 96 weeks. ALS is a progressive nerve disease that weakens muscles. The main goal was to see how safe and tolerable the drug is when taken for a long time, not to cure the disease. P…

This study looked at the long-term safety of an oral form of edaravone in 185 people with ALS. Participants took the medication for 24 to 48 weeks, and researchers tracked any side effects. The goal was to see if taking the drug by mouth is safe over time for managing ALS.

This study tested an experimental drug called MT-7117 in 76 adults with diffuse cutaneous systemic sclerosis, a rare autoimmune disease that causes skin thickening and organ damage. Participants received either the drug or a placebo for 52 weeks. The main goal was to see if MT-71…

This study looked at the long-term safety and effects of an experimental drug called MT-8554 for reducing moderate to severe hot flashes in postmenopausal women. A total of 190 women who had already completed a previous 12-week study took part. Researchers monitored side effects,…

This study tested an experimental drug called MT-2990 in 76 women with surgically confirmed endometriosis who had moderate to severe pelvic pain. The goal was to see if the drug could safely reduce pain, including pain during periods, sex, and other times. Participants were rando…

This study tested an experimental drug called MT-8554 to see if it could reduce the number and intensity of hot flashes in menopausal women. About 375 women who had frequent hot flashes took either the drug or a placebo. The goal was to measure changes in hot flash frequency and …

This study looked at how a single dose of the experimental drug MT-8554 is absorbed, broken down, and removed from the body in 6 healthy men aged 30-55. Researchers measured the drug's levels in blood, urine, and stool over time. The goal was to understand the drug's behavior and…

This study tested whether MT-8554, an experimental drug, changes the heart's electrical activity (QT interval) in 48 healthy adults aged 18-55. Participants received either a low dose, high dose, or placebo. The goal was to see if the drug causes any heart rhythm issues, not to t…